A detailed history of China Universal Asset Management Co., Ltd. transactions in Savara Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 26,035 shares of SVRA stock, worth $115,335. This represents 0.02% of its overall portfolio holdings.

Number of Shares
26,035
Previous 26,035 -0.0%
Holding current value
$115,335
Previous $130,000 0.77%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$4.19 - $5.59 $43,496 - $58,029
10,381 Added 66.32%
26,035 $130,000
Q4 2023

May 21, 2024

SELL
$3.18 - $4.9 $33,011 - $50,866
-10,381 Reduced 39.87%
15,654 $73,000
Q4 2023

Jan 23, 2024

BUY
$3.18 - $4.9 $49,779 - $76,704
15,654 New
15,654 $74,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $505M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.